We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$43B
AUM Growth
-$7.89B
(-16%)
Cap. Flow
-$3.97B
Cap. Flow
% of AUM
-9.24%
Top 10 Holdings %
Top 10 Hldgs %
21.79%
Holding
8,577
New
1,058
Increased
2,469
Reduced
3,270
Closed
1,444
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$158M |
| 2 |
Microsoft
MSFT
|
+$62.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$55.8M |
| 4 |
Boeing
BA
|
+$34.1M |
| 5 |
ARK Innovation ETF
ARKK
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$128M |
| 2 |
NVIDIA
NVDA
|
+$89M |
| 3 |
Apple
AAPL
|
+$86.7M |
| 4 |
Advanced Micro Devices
AMD
|
+$47.6M |
| 5 |
Biogen
BIIB
|
+$30.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.37% |
| 2 | Healthcare | 1.33% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Energy | 0.65% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PIXY
2451
CALL
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
| $955K | ﹤0.01% |
127
| – | – |
|
2452
BlueLinx
BXC
$706M
| $954K | ﹤0.01% |
13,418
-2,332
| -15% | -$159K |
|
2453
Albertsons Companies
ACI
$5.83B
| $954K | ﹤0.01% |
45,990
+20,960
| +84% | +$461K |
|
|
ORGN
2454
CALL
DELISTED
Origin Materials
ORGN
| $953K | ﹤0.01% |
6,890
-5,407
| -44% | -$861K |
|
|
SWTX
2455
CALL
DELISTED
SpringWorks Therapeutics
SWTX
| $952K | ﹤0.01% |
36,600
-11,300
| -24% | -$278K |
|
2456
CALL
Theravance Biopharma
TBPH
$877M
| $951K | ﹤0.01% |
84,800
+64,400
| +316% | +$677K |
|
2457
PUT
PG&E
PCG
$38.5B
| $950K | ﹤0.01% |
58,400
+17,700
| +43% | +$268K |
|
2458
Albemarle
ALB
$15.5B
| $949K | ﹤0.01% |
4,378
-56,176
| -93% | -$15M |
|
2459
PUT
XPEL
XPEL
$1.38B
| $949K | ﹤0.01% |
+15,800
| New | +$1.01M |
|
2460
Invesco
IVZ
$13.9B
| $948K | ﹤0.01% |
52,712
-3,396
| -6% | -$58.1K |
|
|
EXAS
2461
DELISTED
Exact Sciences
EXAS
| $948K | ﹤0.01% |
19,139
-34,439
| -64% | -$1.41M |
|
2462
PUT
Service Corp International
SCI
$11.6B
| $947K | ﹤0.01% |
13,700
+13,200
| +2,640% | +$879K |
|
|
OLOX
2463
Olenox Industries
OLOX
$4.5M
| $946K | ﹤0.01% |
115
-82
| -42% | -$709K |
|
2464
Amylyx Pharmaceuticals
AMLX
$2.54B
| $944K | ﹤0.01% |
25,538
-63,447
| -71% | -$2.25M |
|
2465
CALL
AMC Global Media
AMCX
$489M
| $943K | ﹤0.01% |
60,200
-2,100
| -3% | -$41.5K |
|
2466
PUT
Virgin Galactic
SPCE
$398M
| $942K | ﹤0.01% |
13,540
-7,810
| -37% | -$729K |
|
2467
PUT
QuidelOrtho
QDEL
$838M
| $942K | ﹤0.01% |
11,000
-2,900
| -21% | -$246K |
|
|
CS
2468
DELISTED
Credit Suisse Group
CS
| $940K | ﹤0.01% |
+309,175
| New | +$1.2M |
|
|
NOVA
2469
DELISTED
Sunnova Energy
NOVA
| $939K | ﹤0.01% |
+52,133
| New | +$1.05M |
|
2470
Beam Global
BEEM
$25.3M
| $939K | ﹤0.01% |
53,728
+51,006
| +1,874% | +$763K |
|
2471
CALL
Xeris Biopharma Holdings
XERS
$1.45B
| $938K | ﹤0.01% |
705,400
-45,600
| -6% | -$64.4K |
|
2472
PUT
Ionis Pharmaceuticals
IONS
$9.4B
| $937K | ﹤0.01% |
24,800
+23,000
| +1,278% | +$967K |
|
2473
PUT
PubMatic
PUBM
$810M
| $936K | ﹤0.01% |
73,100
-11,600
| -14% | -$182K |
|
2474
CALL
First Horizon
FHN
$12.1B
| $936K | ﹤0.01% |
38,200
-6,900
| -15% | -$167K |
|
2475
PUT
DXC Technology
DXC
$1.73B
| $935K | ﹤0.01% |
35,300
+15,700
| +80% | +$437K |
|
Similar funds
SCP
Group One Trading's Q4 2022 Portfolio in Review
As of Q4 2022, Group One Trading held 8,577 positions worth $43B, down 16% from $50.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Group One Trading withdrew a net $3.97B in Q4 2022, closing 1,444 positions and reducing 3,270 holdings. Its most notable exit was Biogen, an estimated $30.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 1.4% of assets, down from 1.5% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Group One Trading opened a new position in Cigna worth $165M.
- Group One Trading's largest Q4 2022 buy was Cigna: 497,989 shares worth $165M.
- Group One Trading added most to Microsoft in Q4 2022, an estimated $62.9M increase.
- Group One Trading's biggest Q4 2022 reduction was Tesla, cutting an estimated $128M.
- Group One Trading fully exited Biogen in Q4 2022, selling an estimated $30.6M.
- Group One Trading's ten largest holdings make up 22% of its $43B portfolio in Q4 2022.
- Group One Trading opened 1,058 new positions and closed 1,444 in Q4 2022.
- Group One Trading's portfolio value fell 16% quarter-over-quarter to $43B.
Based on Group One Trading's 13F filing for Q4 2022, filed 9 Feb 2023.